Matthew Wheater

Systemic immune-inflammation index predicts the clinical outcome in patients with metastatic renal cell cancer treated with sunitinib

Cristian Lolli, Umberto Basso, Lisa Derosa et al. · Oncotarget · 2016 · 152 citations · Full text

Medicine, Immunology, Oncology +17

Outcome and Biomarker Analysis from a Multicenter Phase 2 Study of Ipilimumab in Combination with Carboplatin and Etoposide as First-Line Therapy for Extensive-Stage SCLC

Edurne Arriola, Matthew Wheater, Ian Galea et al. · Journal of Thoracic Oncology · 2016 · 115 citations · Full text

Medicine, Oncology, Pharmacology +17

A Randomised Phase 2 Study of AZD2014 Versus Everolimus in Patients with VEGF-Refractory Metastatic Clear Cell Renal Cancer

Thomas Powles, Matthew Wheater, Omar Din et al. · European Urology · 2015 · 100 citations

Medicine, Nephrology, Oncology +14

Clinical activity and safety of Pembrolizumab in Ipilimumab pre-treated patients with uveal melanoma

Ioannis Karydis, Pui Ying Chan, Matthew Wheater et al. · OncoImmunology · 2016 · 88 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +17

Percutaneous hepatic perfusion with melphalan in uveal melanoma: A safe and effective treatment modality in an orphan disease

Ioannis Karydis, Alexandra Gangi, Matthew Wheater et al. · Journal of Surgical Oncology · 2017 · 87 citations · Full text

Medicine, Oncology, Pharmacology +17